학술논문

High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma.
Document Type
Article
Source
HemaSphere; Jan2024, Vol. 8 Issue 1, p1-12, 12p
Subject
Language
ISSN
25729241